Skip to content

Clinical trials

Phase 3 Hypercholesterolemia trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Phase: Phase 3 Country / region: India Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20111
20132
20161
20201
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kowa Research Europe2
LIB Therapeutics LLC2
Novartis Pharmaceuticals2
Amgen1
Daiichi Sankyo1
Kastle Therapeutics, LLC1
PreEmptive Meds, Pvt. Ltd1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia11
Dyslipidemias6
Hyperlipidemias3
Cardiovascular Diseases2
Myocardial Infarction2
Atherosclerosis1
Coronary Artery Disease1
Coronary Stenosis1
Diabetes Mellitus, Type 21
Glucose Intolerance1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.